P2X7 is an ATP-gated membrane ion channel that is expressed by multiple cell types.
| INTRODUCTION
The P2X family contains seven ATP-gated surface membrane receptors (P2X1-P2X7) that form functionally distinct homomeric and/or heteromeric ion channels. 1 The P2X7 receptor is expressed on cells throughout the human body, including the immune and neurological systems, and is implicated in a wide range of physiological processes. 2 P2X7 activation by ATP is a physiological stimulus for the release of interleukin-1β, and proteolytic cleavage of soluble IL-6 receptor, matrix metalloproteinase-9, CD62L, and CD23. [3] [4] [5] Brief exposure to extracellular ATP, released from cellular sources in response to cell stress and tissue damage, induces opening of a nonselective cation channel; while repeated or prolonged application of ATP results in the formation of a transmembrane pore, 6 and ultimately results in cell apoptosis and death via caspase activation. 7 In addition, P2X7 functions as a scavenger receptor, however in contrast to channel and pore functions, phagocytic function is inhibited by ATP. [8] [9] [10] The mechanism by which P2X7 transitions from ion channel to pore in response to the same ligand has not been fully elucidated. However, in vitro studies using wild-type and non-dilating mutant rat P2X7 support partial to full occupancy of ATP-binding sites as a determinant of transition from desensitized states to sensitized/dilated states, respectively. 11 Furthermore, concentration-dependent saturation of ATP-binding sites may explain opposing P2X7-dependent functions observed in human T cell subsets. 12 ATP binding sites are located between each of the three P2X7 protein subunits that form the cation-selective channel. 13 For each of the subunits, the location of conserved amino acid residues required for ATP binding can be inferred from the agonist-bound crystal structure of zP2X4. 14 Within the first subunit, the ammonium groups of lysine 64 and lysine 66, encoded by exon 2 of the P2X7 gene, P2RX7, are predicted to form hydrogen bonds with ATP phosphate groups. In the second subunit, ATP interacts with asparagine 292 and arginine 294, encoded by exon 8, and lysine 311, encoded by exon 9. 15, 16 P2X7 function can be significantly affected by inheritance of an exon 9 single nucleotide polymorphism (SNP) rs28360457 (Arg307Gln) that abolishes P2X7-dependent channel and pore function in human B lymphocytes and peripheral blood mononuclear cells (PBMCs). 17 Alternative splicing of genes produces a variety of alternatively spliced messenger RNAs (mRNAs) that encode distinct proteins, 18 and to date, 11 alternatively spliced isoforms of P2RX7 have been identified. [19] [20] [21] [22] However, only two of these, P2RX7B and P2RX7E, are predicted to be translated to proteins containing the topological features that define members of the P2X receptor family, consisting of two transmembrane domains (TMs), an extracellular loop and intracellular amino, and carboxy termini. 23 P2RX7B gives rise to a protein with a truncated intracellular C-terminus that retains the ATP-binding sites in the extracellular domain, and potentiates channel and pore function when co-expressed with full-length P2RX7A. 20 P2RX7E is identical to P2RX7B except that exons 7 and 8, which encode part of the ATPbinding site in the extracellular domain, are also deleted. 19 There is considerable interindividual variation in P2X7 function that results from inheritance of non-synonymous DNA sequence variations 24, 25 ; however a proportion of this variation may result from alternative splicing. The aim of the present study was to study interindividual differences in P2RX7 alternatively spliced isoform expression, in particular mRNAs that lack exons 7 and 8 (EX7_EX8del mRNA) and within this group identify novel mRNA and protein isoforms that alter receptor function. Furthermore, we aimed to determine if the expression of alternatively spliced variants was heritable.
| MATERIALS AND METHODS

| Cell isolation, RNA, and DNA extraction
The experimental protocol was approved by the Nepean and Blue Mountains Local Health District Human Research Ethics Committee (06/58). After obtaining informed consent, peripheral blood samples were collected from 24 subjects (Table 1) . PBMCs were isolated from whole blood using density gradient centrifugation over Ficoll-Paque (GE Healthcare, Chicago, IL, USA). Isolated cells were preserved at −80°C in RNAprotect (Qiagen, Hilden, NW, Germany) until RNA extraction was performed using Tri-Reagent (Sigma-Aldrich, St. Louis, MO, USA) according to the manufacturer's protocol, using 1-bromo-3-chloropropane as an alternative to chloroform. Reverse transcription was performed at 42°C for 30 minutes using a Tetro cDNA Synthesis kit (Bioline, Taunton, MA, USA) and a 1:1 ratio of oligo dT and random hexamers unless stated otherwise. DNA was isolated from whole blood using a Wizard DNA Extraction kit (Promega, Madison, WI, USA). Sequencing and SNP genotyping were performed at the Australian Genome Research Facility (AGRF, St Lucia, QLD, Australia).
| Reverse transcription PCR
Reverse transcription PCR (RT-PCR) was performed using a Rotor-Gene 2000 cycler (Corbett Life Science; Qiagen) under the following cycling conditions: 95°C for 10 minutes; then 45 cycles at 95°C for 15 s, 55°C for 15 s, 72°C for 15 s followed by a melt curve beginning at 72°C for 45 seconds and increasing to 95°C in increments of 1°C, holding for 5 seconds at each temperature. Each reaction was performed in a volume of 10 µL containing up to 1 µL cDNA, Sensimix Sybr No-Rox Mastermix (Bioline) and 750 nM of appropriate forward and reverse primer (optimal primer concentrations were determined in preliminary experiments, data not shown). For qualitative assessment of P2RX7 isoform profiles, single reactions were performed as described above using primer sets 1-3 (Table 2A ). Products were separated by electrophoresis on a 2% agarose gel containing SybrSafe DNA stain (Thermo Fisher Scientific, Waltham, MA, USA) and visualized on a GelDoc system (Bio-Rad Laboratories, Hercules, CA, USA). Primer sets 4-9 (Table 2B) were used for quantitative RT-PCR (qRT-PCR) and each reaction was performed in triplicate as described above. Expression of each subgroup (amplified by primer sets 5-9, Table 2B ) was measured relative to total P2RX7 expression (amplified by primer set 4, Table 2B ). No-template controls and normalization controls using Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) primers were included in each run.
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To determine transfection ratios of plasmid RNAs in double-transfected HEK 293 cells, cDNA synthesis was performed using oligo (dT)-priming and RT-PCR was performed using Set 4 and Set 9, which detect mRNA transcribed from plasmids P2RX7A or P2RX7L and P2RX7E or P2RX7L, respectively. P2RX7E mRNA derived from the plasmid is truncated in intron 10, unlike naturally occurring P2RX7E mRNA, and is not detected by Set 4 primers in RNA from transfected cells. Fold expression above GAPDH was calculated using the following formula: Fold expression = 1/2 [CT(Set 4 or 9) − CT(GAPDH)] .
| Cloning
PolyA-tailed mRNA was reverse transcribed using a Tetro cDNA synthesis kit (Bioline) as described by the manufacturer at 42°C for 60 minutes. P2RX7 specific sequences were amplified from cDNA using previously described primers 22 and Phusion Hotstart II High Fidelity polymerase (Finnzymes; Thermo Fisher Scientific) with the following cycling parameters: 98°C for 30 seconds followed by 34 cycles at 98°C for 10 seconds, 72°C for 60 seconds, then 72°C for 5 minutes, followed by cloning into a pGemTeasy vector (Promega) according to the manufacturer's instructions except that heat shock was performed in a heat block rather than a water bath. Colony screening was performed using qRT-PCR to identify specific isoform clones as previously described using primer sets 4-9 (Table 2B ). 26 For subcloning into the pcDNA3.1 expression vector, a HindIII site was added to the 5′ end and a GluGlu (EE) Tag and XbaI site were added to the 3′end of P2RX7E and P2RX7L fragments using a common forward primer: 5′-gggaagctttcaccatgccggcctgctgc-3′; and for P2RX7E reverse primer: 5′-ccctctagactcgagctattccattggcatgtattcgtttaaaccgtcacttccttctccaaaccatttt-3′and for P2RX7L reverse primer: 5′-ccctctagactcgagctattccattggcatgtattcgtttaaaccgtaaggactcttgaagccactgta-3′ (restriction sites in bold; EE tag sequence underlined and P2RX7 specific sequence italicized) by amplification using Phusion HotStart II as described above. After double digestion with HindIII and Xba1 (NEB, Ipswich, MA, USA) and gel purification using an Illustra GFX polymerase chain reaction (PCR) and Gelband Purification Kit (GE Healthcare), amplified fragments were ligated into pcDNA3.1 using T4 ligase and transformed into JM109 cells (Promega) according to the manufacturer's instructions. Plasmids were purified from clones of interest using a MiniPrep Plasmid extraction kit (Promega) and sequenced to confirm cloning of the correct P2RX7 isoform sequence. 
| Cell lines
| Exon trapping
DNA sequences spanning P2RX7 exon 7 and flanking intronic sequences were amplified from two subjects (one wild-type and one homozygous minor allele at rs208307) with the addition of BamH1 and Not 1 restriction sites using the following primers: left 5′-acgtaaggatcctgggatttgacgaggtatgg-3′ and right 5′-acgtaagcggccgcccatatgccattggtcacac-3′, and recombinant Pfu DNA polymerase (Thermo Fisher Scientific) according to the manufacturer's standard protocol. The amplified fragments were ligated into linearized pSPL3 vectors (a kind donation from Dr Robert Formosa, DNA Laboratory, Faculty of Health Sciences, University of Malta, Malta) with T4 ligase and transformed into HB101 competent cells (Promega) as described by the manufacturer. Purified plasmids were transfected into HEK 293 cells and harvested for RNA extraction as described above. cDNA synthesis was performed as described above using only oligo (dT)-priming and then PCR was performed as previously described 27 using an annealing temperature of 58°C and pSPL3 specific primers (SD6: 5′-tctgagtcacctggacaacc-3′; SA2: 5′-atctcagtggtatttgtgagc-3′).
| In vitro electrophysiology measurements
HEK 293 cells were transiently transfected with empty vector, P2RX7A, P2RX7E, or P2RX7L constructs. Post-transfection (48 h), cells were detached using 0.5 mL Accutase Cell Detachment Solution (Innovative Cell Technologies Inc, San Diego, CA, USA) and resuspended at a density of 1 × 10 6 -5 × 10 7 cells/mL in 50% serum-free media and 50% external recording solution v/v. The external recording solution comprised 145 mM NaCl, 5 mM KCl, 1 mM MgCl 2 , 2 mM CaCl 2 , 13 mM D-glucose, and 10 mM HEPES (pH 7.4 with NaOH; ~298 mOsm). The internal recording solution comprised 85 mM NaCl, 60 mM NaF, 10 mM EGTA, and 10 mM HEPES (pH 7.2 with NaOH; ~285 mOsm). Solutions were filtered using a 0.2 μm membrane filter (Minisart; Sartorius Stedim Biotech, Goettingen, Germany). Cells were kept in suspension by gentle automatic pipetting. Currents generated by P2X7 were recorded using a NPC-16 Patchliner (Nanion Technologies GmbH, Munich, Germany) patchclamp instrument in the whole-cell configuration. Medium single-hole planar NPC-16 chips with an average resistance of ~2.5 MΩ were used. Pipette and whole-cell capacitance were fully compensated. Recordings were acquired at 1 kHz with the low pass filter set to 0.33 kHz in PATCHMASTER (HEKA Instruments Inc, NY, USA) and performed at room temperature (RT). P2X7 receptor-dependent currents were induced by application of 1 mM ATP. The cells were held at −50 mV. Offline analysis was performed using MATLAB R2015a (The Math Works Inc, Natick, Massachusetts, United States) and GraphPad Prism 6 (Molecular Devices). Data are shown as means ± standard error of the mean (SEM). Statistical analysis was performed using Student's t-test. Statistical differences were considered significant when P < .05.
| Calcium flux measurements
Transfected HEK 293 cells (~2 × 10 6 /mL) were washed once and loaded with 2 μM Fura-Red acetoxymethyl ester by incubation at 37°C for 30 minutes in Ca 2+ free HEPES-buffered NaCl medium. Cells were washed once and incubated in HEPES-buffered NaCl with 1 mM Ca 2+ for another 30 minutes. HEK 293 cells were then washed twice and resuspended in 3 mL HEPES-buffered KCl medium at a concentration of 2 × 10 6 /mL. Samples were stirred at 37°C and stimulated with 1 mM ATP after addition of 3.0 mM CaCl 2 . Cells were analyzed by a Becton Dickinson FACSCalibur flow cytometer at acquisition rates of ~2000 events/s. The kinetic linear mean channel of fluorescence intensity (1024 channels resolution) for each gated subpopulation over successive 6 | SKARRATT eT Al.
2 seconds intervals was plotted against time and saved into a text file as described previously. 28 
| Phagocytosis measurements
Transfected HEK 293 cells (~2 × 10 6 /mL) were resuspended in HEPES-buffered NaCl medium (145 mM NaCl, 5 mM KCl, 10 mM HEPES, pH 7.5, plus 5 mM D-glucose, 0.1% BSA, and 0.1 mM CaCl 2 ). For phagocytosis assays, 1.0 µm (5 µL) of carboxylated yellow-green (YG) beads (Polyscience, USA) were added at zero time. The linear mean channel of fluorescence intensity for gated HEK 293 cells over successive 10 seconds intervals was analyzed by WinMDI software and plotted against time, as described previously. 29 Student's t-test was used to assess differences between mutant and wild-type constructs.
| Cell surface membrane blebbing and cell death assay
To study cell surface membrane blebbing in response to ATP, HEK 293 cells stably transfected with P2RX7A, P2RX7L, or P2RX7E, and non-transfected cells were sparsely seeded into 35 mm dishes. 30 Culture medium was replaced with low divalent medium and after 1 minute ATP was added to a final concentration of 3 mM. 28 Images were collected at RT every 20 seconds over 17 minutes using a Nikon Eclipse 80i microscope with 10x objective, and a Qicam imaging system (QImaging, Surrey, British Columbia, Canada). Sequential images were collated into a time-lapse video (5 frames per second) using Adobe Photoshop (Adobe Inc, CA, US). For treatment with the P2X7 inhibitor, A804598 (Sigma-Aldrich), plated cells were preincubated (15 minutes at 37ºC with 1 µM A804598 in culture medium) and blebbing was monitored as above with A804598 (1 µM) included in the low divalent medium. For the cell death assay, HEK 293 cells stably transfected with P2RX7A, P2RX7L, or P2RX7E, and non-transfected cells in 24-well plates were cultured overnight in the presence and absence of ATP (1 mM) and the number of viable and nonviable cells present in the supernatant was evaluated using a hemocytometer and trypan blue exclusion.
| Ethidium bromide uptake measurements
P2X7 pore function in transfected HEK 293 cells was assessed by ATP stimulated ethidium + uptake as previously described using either a plate reader based assay 31 or by time resolved flow cytometry. 32 Briefly, cells were bathed in a low divalent medium containing ethidium bromide (25 µM) and opening of the P2X7 pore was stimulated by the addition of 1 mM ATP allowing passage of ethidium + into the cell. The increase in fluorescence signal as the ethidium + binds to DNA was monitored over time.
| Preparation of whole-cell lysates
Cells were placed on ice and washed three times with cold phosphate-buffered saline (PBS) and harvested by scraping in the presence of 0.5 mL PBS with mini-Complete Protease Inhibitor cocktail EDTA-free (PI, Roche Holding AG, Basel, Switzerland). Pelleted cells were lysed with 50 µL TX-100 lysis buffer (1% Triton-X-100 in PBS plus PI). After 30 minutes on ice, whole-cell lysates were harvested by centrifugation (14 000g, 10 minutes at 4°C).
| Western blotting
Equal amounts of protein were heated at 70°C for 10 minutes in NuPAGE loading buffer (Invitrogen) with or without 5 mM Dithiothreitol (DTT). Samples and markers (Hyperpage, or Novex Sharp Protein Standard, Invitrogen) were separated on NuPAGE Novex 4%-12% Bis-Tris mini gel in a XCell SureLock mini-Cell system with NuPAGE MOPS SDS Running Buffer (all from Invitrogen) by running at 60 V for 30 minutes followed by 120 V for 120 minutes or Tris-Acetate mini gels with NuPAGE Tris-Acetate SDS Running Buffer as indicated. Proteins were transferred to a Polyvinylidene fluoride (PVDF) membrane (Thermo Fisher Scientific) using an XCell II Blot Module (Bio-Rad Laboratories, Hercules CA, USA; 350 mA for 50 minutes) in NuPAGE Transfer Buffer (Invitrogen).
After blocking for 2 hours or overnight with non-animal protein (NAP)-blocker (G-Biosciences, St. Louis, MO, USA) and washing three times in 0.05% Tween20 in Tris-Buffered Saline (TBS) for 10 minutes with shaking, the membrane was incubated with primary antibodies (polyclonal rabbit anti-Glu-Glu antibody (Anti-EE), Bethyl Laboratories, Montgomery, TX, USA, 1:10 000) or extracellular P2X7 antibody, APR-008, (anti P2X7, Alomone Labs, Jerusalem, Israel; 1:500) for 2 hours, washed again as above and probed with goat anti-rabbit horseradish peroxidase (Santa Cruz Biotechnology, Dallas, TX, USA, 1:10 000) for 1 hour. After further washing, bands were visualized using a SuperSignal West Pico or Femto kit (Thermo Fisher Scientific) on a Gel Doc System (Bio-Rad).
For near infrared immunoblotting, proteins were transferred to Immobilon-FL membranes (Merck Millipore, Tullagreen, Ireland) by overnight transfer at 30 V. Membranes were rinsed with water and dried for 1 hour before re-wetting | 7 SKARRATT eT Al. and blocking for 1 hour in Odyssey Blocking Buffer (OBB, Licor, Lincoln, NB, USA) prepared in TBS as described by the manufacturer. Primary antibodies were used as described above; except they were prepared in OBB plus 0.1% Tween 20. Washes were performed as above, but with 0.1% Tween 20. Blots were incubated with secondary antibody (800CW Donkey anti-Rabbit IgG, Licor) diluted 1:20 000 in OBB plus 0.1% Tween 20 plus 100 µg/mL sodium dodecyl sulfate for 1 hour in the dark. The blots were washed four times, rinsed in TBS and air dried in the dark. Images were collected on an Odyssey Fc Imager (Licor).
| Immunofluorescent staining for flow cytometry
Transfected HEK 293 cells were stained either directly with anti-P2X7 monoclonal antibody (mAb) L4-FITC (1:200), or indirectly with anti-P2X7 (1:40) and goat anti rabbit IgG-FITC (Santa Cruz Biotechnology,1:200) and analyzed using a FACSVERSE flow cytometer (BD Biosciences, Franklin Lakes, NJ, USA).
| Crosslinking of cell surface receptors
All crosslinking was performed on cells attached to culture flasks. To crosslink surface receptors with Bis (sulfosuccinimidyl) suberate (BS3, Thermo Fisher Scientific), cells were washed three times with cold PBS (pH 8) and incubated with 1.25 mM BS3 for 30 minutes at RT. The reaction was quenched by addition of 20 mM Tris HCl (pH 7.5) followed by incubation at RT for 15 minutes. Cells were harvested for western blotting as described above. Crosslinking with 0.5 mM 3,3′-dithiobis (sulfosuccinimidyl propionate) (DTSSP, Thermo Fisher Scientific) was performed as above except that PBS (pH 7.4) was used.
| Proximity ligation assay (PLA)
Dishes (35 mm) of subconfluent HEK 293 cells stably transfected with EE-labeled P2RX7A or P2RX7L were transiently transfected with 0.25 µg of P2RX7A-AcGFP plasmid. After 24 hours, cells were trypsinized and a 1/5 dilution replated onto poly-D-Lysine coated coverslips in a 24 well plate. After a further 24 hours, cells were fixed by washing once with cold PBS, then incubating for 20 minutes on ice with 4% paraformaldehyde in PBS. Fixed cells on coverslips were washed twice with PBS and permeabilized with 0.5% Triton X-100 in PBS for 10 minutes at RT, then blocked for 30 minutes at RT in 5% FCS in PBS.
Coverslips were incubated overnight at 4°C with rabbit anti-EE (1/800) and mouse anti-GFP antibody (1/800, Santa Cruz Biotechnology). Coverslips were then attached to slides with Twinsil (Picodent, Wipperfürth, NW, Germany), cellside-up before proceeding with the proximity ligation assay (PLA) using a Duolink In Situ Orange mouse/rabbit starter kit (Sigma-Aldrich, St Louis, MO, USA) according to the manufacturer's instructions. Signals were observed with an Eclipse 80i fluorescent microscope with a 40x objective using B2A, G2A and UV-2A filter sets (Nikon Instruments, Melville, NY, USA) to detect AcGFP, PLA, and DAPI signals, respectively. Images were collected with a Qicam Fast1394 camera (Qimaging, Surrey, BC, Canada) using a constant, optimized exposure time for collection of all images.
| Nickel affinity chromatography
Pull-down of His-tagged proteins was performed using EZview Red HIS-Select HC Nickel Affinity beads as described by the manufacturer (Sigma-Aldrich). Briefly, whole-cell lysates (~1 µg protein) were incubated with pre-equilibrated beads in the presence of 10 mM or 12.5 mM Imidazole in TX-100 lysis buffer, for 2 hour at 4ºC with slow rotation, then washed four times with the same buffer. Proteins were eluted from the washed pellet in 15 µL of NuPAGE loading buffer (Invitrogen) with or without 5 mM DTT as required.
| Statistical analyses
Fisher's exact tests were performed using an online tool (www.quant psy.org/fishe r/fisher.html) and one-way ANOVA with Tukey's post hoc analyses were performed in GraphPad Prism v7. Pairwise linkage disequilibrium (LD) was calculated using PLINK (http://pngu.mgh.harva rd.edu/purce ll/ plink /). 33 
| RESULTS
| Expression patterns of P2RX7 mRNA isoforms vary between human subjects
PBMCs from 23 human subjects (the gel for 1 of 24 subjects was unavailable) were used to qualitatively determine interindividual differences in expression of P2RX7 mRNA isoforms (Table 1) . PCR primers (Sets 1-3, Table 2A ) were designed to span known alternatively spliced regions of the P2RX7 primary mRNA transcript. Each set of primers generated amplicons of different sizes, depending on the isoforms present in the sample which, when assessed by Southern blot, enabled a qualitative analysis of P2RX7 isoform expression. The predicted banding patterns in the presence of all known P2RX7 isoforms are represented schematically in Figure 1A (left panel) alongside two examples of typical isoform expression patterns seen in individuals ( Figure  1A , central and right panels). Reduced complexity of banding patterns in individuals compared to the predicted patterns indicated that a subset of P2RX7 mRNA isoforms are normally expressed and in varying abundances. In subject 1, absence of a 130 base pair (bp) band generated by primer Set 1 indicated negligible expression of P2RX7V7 and P2RX7ΔE2; absence of 385, 159 and 135 bp bands from Set 2 indicated negligible expression of P2RX7V4, C and F, and D, respectively; and absence of a 199 bp band from Set 3 excluded P2RX7E. Weak detection of a 438 bp band generated by Set 1 indicated low levels of isoforms P2RX7G and/or H, and detection of a 329bp band by Set 3 indicated the presence of P2RX7J. From these data, it was inferred that of 12 known P2RX7 isoforms, subject 1 predominantly expressed isoforms P2RX7A, P2RX7B, and P2RX7J. Of interest was the interindividual differences in the presence of the 199 bp band detected by Set 3 (Figure 1A , arrow) representing Ex7_Ex8del mRNAs, which was absent in 10 of 23 subjects tested.
P2RX7 mRNA isoforms can be grouped on the basis of specific exon deletions or insertions. 19 A set of six primers were designed to enable relative quantification of each isoform subgroup as a percentage of total P2RX7 mRNA in all 24 subjects (Tables 1, 2B primer sets 4-9, and Figure 1B) . The cohort consisted of 11 subjects with a lymphoproliferative disorder (LPD) and 13 healthy individuals. The proportions of isoform subgroups expressed in LPD subjects was not significantly different to healthy individuals, however total P2RX7 expression was higher relative to GAPDH in the LPD group [Delta C T (Set 4-GAPDH) = 4.87 (± 0.155 SEM) in healthy subjects and 3.96 (± 0.263) in LPD subjects, delta Ct inversely related to expression level, P = .005, Student's t-test]. In PBMCs, the inserted intron 10 (Ins Int 10) mRNA group (containing P2RX7B, P2RX7C, P2RX7E, P2RX7G, P2RX7V4, and P2RX7V7) was the most abundant in each individual (mean = 60.7% ± 12.2 SD), followed by deletion Exon 4 (P2RX7C and P2RX7F; mean = 10.4% ± 4.8 SD), and deletion Exon 8 (P2RX7J, P2RX7F, and P2RX7V4; mean = 5.9% ± 3.0 SD). Ins N3 variants (P2RX7G and P2RX7H) were consistently least abundant ( Figure 1B ; mean = 0.5% ± 0.7 SD). Ex7_Ex8del mRNA (P2RX7E) was detected at levels ranging from 0%-13% of total P2RX7 (mean = 3.2% ± 3.4 SD), consistent with qualitative analyses.
| Isolation of a novel EX7_EX8del mRNA variant
To investigate whether interindividual variation in EX7_ EX8del mRNA variants was due to P2RX7E levels alone or the presence of other variants, P2RX7E mRNA was cloned from two subjects that expressed high levels of EX7_EX8del mRNA. Colony screening was performed using primer sets 4-9 (Table 2B ) to identify clones of specific isoforms as previously described. 26 In addition to isolating P2XR7E mRNA, which is predicted to be translated into a 275 amino acid (aa), 31.3 kDa protein; five novel P2RX7 mRNA variants were identified ( Figure S1 ). Of interest was a novel EX7_EX8del mRNA isoform designated "P2RX7L" (Figures 2 and S1 ; GenBank accession, MK465687) that was predicted to be translated into a 506 aa, 58 kDa, protein retaining the long intracellular C-terminus of P2X7A ( Figure S2 ).
F I G U R E 1 Qualitative and Quantitative Expression patterns of
P2RX7 mRNA isoforms in PBMCs. A, Primer sets 1-3, described in Table 2A , were used to qualitatively assess interindividual differences in P2RX7 mRNA isoform expression in PBMCs from human subjects (n = 23) by agarose gel electrophoresis of RT-PCR products. Left panel: predicted banding patterns; centre and right panel: banding patterns from two representative subjects. The most commonly observed difference between subjects was the presence or absence of a 199 bp band in Subject 2 lane S3 (arrow). Panels are from the same image with irrelevant lanes cropped out. *Molecular size marker: 100 bp DNA ladder; **Negative control. B, Quantitative assessment of the abundance of P2RX7 mRNA isoform groups relative to total P2RX7 mRNA was made by qRT-PCR using primer sets 4-9 (Table  2B ) and expressed as a percentage of total P2RX7 mRNA in PBMCs from human subjects (n = 24) | 9 SKARRATT eT Al.
| EX7_EX8del mRNA levels are associated with an intron 6 SNP, rs208307
From our SNP genotyping database, we identified four P2RX7 SNPs that were predicted to influence exon 7 and 8 skipping: rs208307 (acceptor splice site in intron 6), rs503720 (upstream of the intron 7/exon 8 junction), rs7958311 (exon 8 missense mutation), and rs7958316 (exon 8 missense mutation at an exonic splice enhancer site). Allele frequencies of these SNPs were compared between subjects that either expressed or did not express EX7_EX8del mRNA ( Table 3 ). The minor allele frequency (MAF) of rs7958311 was significantly higher in EX7_EX8del negative subjects (MAF = 0.5) compared to positive subjects (MAF = 0.15; n = 17; P = .02). Conversely the MAF for rs208307 was 0 for EX7_EX8del negative subjects compared to 0.43 for EX7_ EX8del positive subjects (P = .007). No associations were found between EX7_EX8del mRNA levels and the other two SNPs (rs503720 and rs7958316).
Among the EX7_EX8del positive subjects, the lowest level of expression was seen in subjects wild-type at rs208307. To determine if EX7_EX8del mRNA levels were associated with gene-dosage of rs208307, we analyzed EX7_ EX8del mRNA levels as a percentage of total P2RX7 mRNA in wild-type (CC), homozygote minor allele (GG), and heterozygote (CG) subjects and found a difference between the three groups (one-way ANOVA P < .0001 followed by Tukey's post hoc analysis). Expression of EX7_EX8del mRNA was highest in subjects homozygous for the minor allele (mean expression = 9.1% ± 4.5 SD), intermediate in heterozygote (mean = 5.0% ± 1.8 SD), and lowest in wild-type participants (mean = 0.5% ± 1 SD, Figure 3A ). Gene dosage of rs7958311 was not associated with levels of EX7_EX8del mRNA (data not shown).
| A SNP haplotype block tagged by rs208307 regulates EX7_EX8del mRNA levels
The rs208307 SNP is located 5 bp from the intron 6/exon 7 boundary, and is predicted to disrupt a branch-point site associated with exon splicing [Human Splice Finder 2.4.1 software (HSF), http://www.umd.be/HSF/]. 34 An exon-trapping system was used to study the effect of rs208307 wild-type (CC) and homozygous minor allele (GG) on P2RX7 splicing ( Figure 3B) . A 494 bp DNA fragment encompassing P2RX7 exon 7 and flanking intronic sequences was cloned from one wild-type (CC) subject and one homozygous minor allele (GG) subject and inserted into a pSPL3 exon trapping vector. HEK 293 cells were transiently transfected with either CC, GG, or empty trapping vectors. RT-PCR was performed on extracted RNA using plasmid specific primers SD6 and SA2. Cells transfected with plasmid derived from the wild-type subject, produced a 393 bp band ( Figure 3C) , which was confirmed by sequencing to contain P2RX7 exon 7. The plasmid derived from the homozygous minor allele subject generated two fragments, a 393 bp amplicon containing P2RX7 exon 7, as well as a 263 bp amplicon confirmed by sequencing to contain only Exon 1 and Exon 2 of pSPL3, consistent with partial exon 7 skipping ( Figure 3C ).
Sequencing of the 494 bp fragments inserted into the exon trapping plasmid identified additional SNPs surrounding rs208307 that were subsequently analyzed in silico for their effect on alternative splicing (HSF and RegRNA software, http://regrn a2.mbc.nctu.edu.tw/). 34, 35 The rs208307 homozygous minor allele subject was homozygous for Fisher's exact test was used to determine differences between MAF in the two groups.
minor alleles at rs208306, rs36144485 (both in intron 6), and rs208308, rs208309, and rs373655596 (all in intron 7).
In silico analysis predicted that rs208306 SNP would introduce a new regulatory site that may enhance alternative splicing (RegRNA) and an exon identity element analysis predicted disruption of a silencing element (HSF). The rs36144485 variation is a 4 bp deletion (TGTT) that is predicted to disrupt silencing motifs IIE (intron identity elements) sites. The rs208307 wild-type subject was wild-type at each of these SNPs, however heterozygote at rs17526121 in intron 6 that is predicted to disrupt a potential branchpoint site (HSF).
To determine if the seven variants identified in introns 6 and 7 are inherited as a haplotype block tagged by rs208307, a further eight subjects were genotyped (Table 4 ) and pairwise LD was calculated using PLINK (http://pngu. mgh.harva rd.edu/purce ll/plink /). 33 Complete LD was found between rs36144485, rs208307, rs208308, rs208309, and rs373655596 (r 2 = 1); and rs208306 was in high LD with each of these 5 SNPs (r 2 = 0.8).
| Homomeric P2X7L complexes are expressed on the cell surface membrane
To study protein expression of EX7_EX8del alternatively spliced mRNAs, P2RX7A (PJB3), P2RX7E, and P2RX7L EE-labeled constructs were transfected into HEK 293 cells. Whole-cell lysates of transfected cells were analyzed by Western blot and probed using anti-EE. Proteins were detected at ~68, 31 and 58 kDa ( Figure 4A, lanes 2, 3, and 4 ) which corresponded to the expected molecular weights (MW) of P2X7A, P2X7E, and P2X7L, respectively. To study cell surface expression of EX7_EX8del alternatively spliced protein isoforms, HEK 293 cells were transiently transfected with P2X7A, E, or L and analyzed by flow cytometry after labeling with extracellular anti-P2X7 polyclonal antibody (pAb) APR008 raised against amino acids 136-152 of P2X7A and encoded by exons 4 and 5 ( Figure 4B , top panels). Surface expression of P2X7A and P2X7L, but not P2X7E was observed. Lack of surface expression of P2X7E is consistent with absence of the C-terminal that contains key structural motifs required for cell surface localization. 36, 37 P2X7 surface expression was also analyzed using the L4 mAb that binds to an epitope around Arg307 and inhibits receptor function. 38 L4 binding was detected on the surface of P2X7A transfected HEK 293 cells, however no binding was detected in P2X7E or P2X7L transfected cells ( Figure 4B , bottom panels).
To determine if P2X7L protein isoforms interact on the surface membrane, HEK 293 cells were transiently transfected with EE-tagged P2RX7A or P2RX7L expression constructs. Proteins on the cell surface were cross-linked by treatment with BS3, a membrane impermeable noncleavable protein crosslinker ( Figure 4C ). For BS3-treated P2RX7A-transfected cells, bands at > 160kDa, ~130 kDa and ~70 kDa, corresponding to trimers, dimers, and monomers, respectively, were detected by Western blotting (Figure 4C,  lane 2) . For BS3-treated P2RX7L-transfected cells, bands F I G U R E 3 EX7_EX8del mRNA levels are associated with gene dosage at rs208307. A, Expression levels of EX7_EX8del mRNA between subjects who were wild-type (n = 10), heterozygous (n = 8), or homozygous (n = 2) at rs208307(genotyping data for 4 subjects unavailable). There was a difference between the three groups (one-way ANOVA P < .0001 followed by Tukey's post hoc analysis). *P = .0005; **P < .001; ***P < .018. WT, wild-type; HET, heterozygote; HOM, homozygote. B, Schematic representation of the structure of the exon trapping vector, pSPL3, containing a 494 bp fragment of P2RX7 spanning Exon 7 from 2 subjects either WT or HOM, respectively, at rs208307. MCS, multiple cloning site. C, HEK 293 Cells were transfected with one of the two plasmids or empty pSPL3 vector and total mRNA was isolated. RT-PCR was performed, and PCR products were resolved on a 2% agarose gel. The WT plasmid generated a 393bp mRNA fragment, while the mutant plasmid generated a 393bp fragment and a 263bp fragment identical to the empty vector. M, DNA ladder. Panels from the same image with irrelevant lanes cropped out | 11 SKARRATT eT Al.
at ~110 kDa and ~55 kDa were detected ( Figure 4C, lane 4) , which corresponded to the expected MWs of dimers and monomers, respectively. Although dimers of P2X7L crosslinked at the cell surface were identified, P2X7L trimers were not detected ( Figure 4C, lane 4) .
| Heteromeric P2X7L and P2X7A complexes are expressed in the cell cytoplasm and surface membrane
Nickel affinity chromatography was used to determine if P2X7A and P2X7L form heteromeric complexes in the cell cytoplasm. HEK 293 cells were stably transfected with P2X7A-His and P2X7L-EE expression constructs or P2X7L-EE alone. EZview His-Select beads were used to pull down proteins interacting with P2X7A-His from whole-cell lysates in the presence of 10 mM imidazole. Samples of the whole-cell lysates and the bead eluates were separated by Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and Western blot was performed using near infrared immunoblotting ( Figure 5A ). When expressed together in the same cell line, P2X7L-EE co-eluted with P2X7A-His ( Figure 5A, lane 4) , but when expressed alone, P2X7L-EE was only detected at residual levels in the bead eluate ( Figure 5A,  lane 3) indicating that P2X7A and P2X7L interact in a heteromeric complex.
A Duolink PLA was used to validate the observation that P2X7L interacts with P2X7A. Non-transfected HEK 293 cells or cells stably transfected with P2RX7L-EE or P2RX7A-EE were transiently transfected with P2X7A-AcGFP and a PLA was performed. All three cell lines were successfully transfected with P2RX7A-AcGFP (green fluorescence, Figure 5B , upper row). Positive PLA signals were detected in both P2X7A-EE and P2X7L-EE stable cell lines (red fluorescence, Figure 5B , middle row), but not in HEK 293 cells, indicating that P2X7L-EE may form a heteromeric complex with P2X7A-AcGFP.
To determine if P2X7A and P2X7L form heterotrimers in the cell surface membrane, HEK 293 cells stably transfected with P2RX7A-His and P2RX7L-EE or P2RX7L-EE alone were treated with DTSSP, a membrane impermeable crosslinker. Nickel affinity chromatography was used to purify receptor complexes containing P2X7A-His from whole-cell lysates in the presence of 12.5 mM imidazole. Bead eluates and wholecell lysates were separated by nonreducing SDS-PAGE and near infrared immunoblotting Western blots were performed. The presence of P2X7L alone or P2X7L and P2X7A in wholecell lysates was confirmed by probing duplicate blots with anti-EE to detect P2X7L-EE ( Figure 6A lanes 1 and 2, between 50 and 60 kDa) or with anti-P2X7 antibody (APR008) that detects both P2X7A-His ( Figure 6A lane 4 , between 60 and 80 kDa) and P2X7L-EE ( Figure 6A Lanes 3 and 4 between 50 and 60KDa). Although the absence of DTT has resulted in a diffuse banding pattern, faint bands at ~110kDa and ~170kDa corresponding to the predicted MW of P2X7L dimers and trimers, respectively, were detected in whole-cell lysates of cells expressing P2X7L alone (Figure 6A lane 3) and less distinctly in the other lanes. As observed previously ( Figure 5 ), small amounts of P2X7L-EE were eluted from whole-cell lysates using the His select beads ( Figure 6A, lanes 1 and 3) . Probing blots with anti-EE and anti-P2X7 detected a band at ~170 kDa corresponding to the predicted MW of a P2X7L-EE homotrimer ( Figure 6B lane, 1 and 3, bold arrows) .
Three distinct bands corresponding to the MWs of P2X7A-His monomers, dimers and trimers were detected in bead eluates of doubly transfected cells probed with anti-P2X7 ( Figure 6B, lane 4) , but not with anti-EE ( Figure 6B  lane 2) . A Western blot of bead eluates from doubly transfected cells probed with anti-EE ( Figure 6B lane 2, chevron arrow) detected a complex that migrated midway between the position of the P2X7A dimer (A2, ~160kD) and trimer (A3,~260kD, Figure 6B lane 4) and slightly behind the P2X7L trimer faintly detectable at ~170kDa ( Figure 6B  lanes 1 and 3) , consistent with formation of a heterotrimer of P2X7A-His and P2X7L-EE. At the corresponding position on the blot probed with anti-P2X7 ( Figure 6B, lane 4) only a dark smear rather than a distinct band was observed. Heterotrimerization and/or cell surface crosslinking may have obscured the anti-P2X7 binding site as it is located in F I G U R E 4 Protein expression of P2X7L. A, Western blot analysis of whole-cell lysates from HEK 293 cells transfected with EE-labelled P2RX7A, E and L expression constructs. Whole-cell lysates were immunoblotted with anti-EE antibody. Proteins were detected at ~68, 31 and 58 kDa that corresponds to the expected molecular weights (MW) of P2X7A (solid arrow), P2X7E (chevron arrow), and P2X7L (thin arrow), respectively. Panels are from the same image with irrelevant lanes cropped out. B, Flow cytometry analyses of HEK 293 cells transiently transfected with P2X7A, E or L labelled with APR008 anti-P2X7 pAb (upper panels) or L4 mAb (lower panels). APR008 was positive for P2X7A and P2X7L, but not P2X7E. L4, which binds to an epitope located around Arg307, was positive for P2X7A, but not P2X7E or P2X7L. C, Western blot analysis of whole-cell lysates from HEK 293 cells following protein crosslinking. HEK 293 cells were transiently transfected with EEtagged P2X7A or L expression constructs and cross-linked with BS3. Immunoblots were probed with anti-EE. Trimers, dimers, and monomers of P2X7A (A 3 , A 2 and A, respectively) and dimers and monomers of P2X7L (L 2 and L, respectively) were detected. Panels are from the same image with irrelevant lanes cropped out | 13 SKARRATT eT Al.
the extracellular domain but not the anti-EE epitope, which is located on the intracellular C-terminus of P2X7L-EE. The doublet observed in Figure 6B. (lanes 1 and 2 at approximately 110kDa) is likely to correspond to endogenous HEK 293 proteins with naturally occurring EE and His epitopes.
| P2X7L has phagocytic but not channel or pore function
To determine whether EX7_EX8del protein isoforms form functional receptors, patch-clamping and Ca + flux was used to measure channel function, and ethidium + uptake measured by time resolved flow cytometry was used to analyze pore function in HEK 293 cells transiently transfected with either P2X7A, P2X7L, or P2X7E. In addition, phagocytic function, in the absence of ATP, was analyzed by measuring the uptake of YG beads using flow cytometry. 8, 9, 39 Channel and pore function were not detected in either P2X7E or P2X7L transfected cells ( Figure 7A-C) , however P2X7L showed the same level of phagocytic function compared to P2X7A ( Figure 7D ). P2X7E, which is not trafficked to the cell surface, failed to confer phagocytic function ( Figure 7D ). Figure 6A,B, lanes 1 and 2) or with anti-P2X7 antibody to detect P2X7A-His and P2X7L-EE ( Figure  6A,B, lanes 3 and 4) . Panels are from the same image with irrelevant lanes cropped out. A, A2, and A3 indicate monomers, dimers and trimers of P2X7A-His, respectively. Bold arrows indicate the position of P2X7L-EE trimers; chevron arrow indicates the position of the P2X7L-EE/P2X7A-His heterotrimer
| P2X7 receptor-dependent cell membrane blebbing is absent in HEK 293 cells expressing P2X7E or P2X7L
Exposure to ATP (3 mM) induced changes in cell shape in HEK 293 cells transfected with P2RX7A, P2RX7E, P2RX7L, and non-transfected cells (Figure 8A ,B, and Supporting Videos S1-S5). Membrane blebbing, indicating P2X7 receptor activation, 30 was observed in cells transfected with P2RX7A, however cells transfected with P2RX7E or P2RX7L did not exhibit blebbing. ATP-induced blebbing in P2RX7A transfected cells was inhibited by A804598 (1 µM), a specific P2X7 antagonist ( Figure 8A , and Supporting Videos S1-S5).
| Exposure to ATP induces cell death in cells expressing P2X7A but not P2X7E or P2X7L
Activation of P2X7 induces apoptosis and cell death. 7 HEK 293 and transfected cell lines grow as a monolayer detaching from the stratum into the culture supernatant upon cell division or when cell death occurs. Following addition of ATP (1 mM), substantial numbers of P2RX7A transfected cells were released into the supernatant of which 99.6% were nonviable (determined by trypan blue uptake; data not shown). However, ATP did not induce cell death in P2RX7L or in P2RX7E transfected cells ( Figure 8C ).
| P2X7 receptor pore function is altered following double-transfection of P2RX7A and P2RX7L
Since co-assembly of P2X7A with the C-terminus deleted P2X7B protein isoform potentiates P2X7 pore function, 20 ethidium + uptake was studied in HEK 293 cells that had been double-transfected with P2RX7A and either P2RX7E or P2RX7L. P2XR7A was co-transfected with equal amounts of P2RX7E or P2RX7L (1 µg total plasmid DNA) and cells transfected with single plasmids were included as controls. Pore function was measured by ATP-induced ethidium + uptake using a plate readerbased assay. Confirming earlier observations using time resolved flow cytometry ( Figure 7C ), single transfections of P2RX7L and P2RX7E showed no ethidium + uptake. Pore function was unchanged following co-transfection of P2RX7A and P2RX7E, however, co-transfection of P2RX7A and P2RX7L reduced the rate of ethidium + uptake by ~50% (Figure 9 , P < .0001). Cell surface expression of P2X7A and P2X7E or P2X7L could not be measured by flow cytometry as currently there are no antibodies that differentiate P2X7A from EX7_EX8del protein isoforms. Expression of protein isoforms was inferred from plasmidderived mRNA expression in transfected cell populations using primer sets 4 (mRNA derived from P2X7A and P2X7L plasmids) and 9 (mRNA from P2X7E and P2X7L plasmids; Table 2 ). Cells double-transfected with P2RX7A and P2RX7E showed similar levels of mRNA expression determined by sets 4 and 9. Similarly, approximately equal amounts of P2RX7A and P2RX7L mRNAs were expressed, with P2RX7A + P2RX7L mRNAs measured by set 4 expected to be double expression of P2RX7L measured by set 9 (Table S1 ). 
| DISCUSSION
In this paper, we report cloning and expression of a novel P2RX7 splice variant, P2RX7L, which is characterized by skipping of exons 7 and 8. A six SNP haplotype was found to induce partial allele-specific alternative splicing, increasing mRNA levels of EX7_EX8del splice variants. Deletion of exons 7 and 8 will excise asparagine 292 and arginine 294 residues, both of which are predicted to interact with ATP in the ligand-binding site of human P2X7. 40 Significantly, P2X7L was found to form a heteromeric complex when coexpressed with P2X7A. In transfected HEK 293 cells, P2X7L showed phagocytic, but not membrane blebbing, cell death, channel, or pore function in response to ATP. Compared to P2X7A alone, double-transfection of P2X7L and P2X7A reduced pore function by ~50%.
P2RX7 mRNA isoforms were studied in human PBMCs using a novel method that combined qualitative RT-PCR and qRT-PCR. For qualitative RT-PCR, three primer sets ( Table  2 , sets 1-3) were designed to distinguish between splice isoforms based on amplicon size whereas for qRT-PCR, P2RX7 specific primers were designed to target sites of either intron-retention, exon-skipping, or alternative exon insertion ( Table 2 , sets [4] [5] [6] [7] [8] [9] . In contrast to the qualitative primer sets, quantitative primer sets were designed to detect a single splicing feature, generate small amplicons to ensure amplification efficiency, and where possible span exon-exon boundaries. Considerable interindividual variation was observed in both qualitative and quantitative analyses particularly with respect to Ex7_Ex8del mRNA levels ( Figure 1A,B ). This finding was significant considering EX7_EX8del is predicted to excise the P2X7 ATP-binding site based on mutagenesis studies and the crystal structure of zP2X4. 40, 41 Participant genotypes were examined, and an association was found between low or absent EX7_EX8del and the minor allele at rs208307 (641-5C > G) that is located at an acceptor splice site in intron 6. In contrast, the highest levels of EX7_ EX8del mRNAs were found in rs208307 homozygote minor allele subjects (Table 3 ). EX7_EX8del mRNA transcript levels correlated with allele-dosage of rs208307, with the highest levels in homozygote, intermediate in heterozygote, and lowest in wild-type ( Figure 3A) . However, it is likely F I G U R E 8 ATP induced blebbing in cells expressing P2X7A but not P2X7L or P2X7E. Cells expressing P2X7 isoforms were exposed to 3mM ATP as described in the methods. A, Cells expressing P2X7A in the presence and absence of 1uM A804598 at 0, 3, 9, and 15 min after ATP addition are shown. Cell surface membrane blebbing is seen at 3, 9, and 15 min. in P2X7A cells (block arrows) that is inhibited by A804598. B, Non transfected HEK 293 cells or cells expressing P2X7E or P2X7L at 0 and 15min after addition of 3 mM ATP. Images are representative of 2-3 experiments. Images have been cropped to highlight a cluster of cells. Original images are compiled in Supporting Videos S1-S5. C, Exposure to ATP induced cell death in cells expressing P2X7A but not P2X7E or P2X7L. Confluent monolayer cultures of cells expressing P2X7 isoforms were cultured overnight in the presence or absence of 1 mM ATP and the density of cells released to the supernatant was evaluated with uptake of trypan blue (n = 3, Students t-test *P < .05) that other pre-mRNA processing events regulate skipping of exons 7 and 8, as rs208307 homozygote minor allele participants continue to express mRNA isoforms that retain exons 7 and 8. Furthermore, some subjects homozygote wild-type at rs208307 also expressed EX7_EX8del mRNAs at low levels. These results are consistent with partial allele-specific alternative splicing that was confirmed using an exon trapping system by cloning DNA fragments encompassing P2RX7 Exon 7 and flanking intronic sequence into an pSPL3 trapping vector. The haplotype tagged by rs208307 (minor alleles at rs208307, rs208306, rs36144485, rs208308, rs208309, and rs373655596) demonstrated partial allele-specific alternative splicing by generating transcripts both with and without inclusion of Exon 7 ( Figure 3C ). Similar to other genes, 42 we have shown that P2RX7 undergoes allele-specific alternative splicing, and that inheritance contributes to differences in relative abundances of EX7_EX8del mRNAs. However, multiple factors regulate alternative splicing including cell type-specific and physiological mechanisms, 43 for example, expression of P2X7B is increased in B lymphocytes following stimulation with phytohemagglutinin. 20 Alternative splicing has been shown to produce eleven human P2RX7 mRNA isoforms, however only two truncated protein isoforms, P2X7B and P2X7J, have previously been studied at the protein level. [19] [20] [21] [22] 44 P2RX7B retains intron 10, which introduces a new stop codon and encodes a truncated protein lacking the last 171 aa and containing an alternate 18 aa after TM2. 20 P2X7B forms a heterotrimer with P2X7A when exogenously expressed in Xenopus laevis oocytes and increases receptor functions when co-transfected with P2X7A in HEK 293 cells. 20 P2X7J lacks the entire intracellular C-terminus, TM2, and the distal third of the extracellular loop. 21, 44 In HEK 293 cells, P2X7J also forms a heterotrimeric complex with P2X7A, however, P2X7 functions are inhibited in co-transfected Madin-Darby canine kidney cells. 45 In the present study, a novel EX7_EX8del isoform, P2RX7L, was identified after mRNA sequences were cloned from subjects that expressed relatively high levels of EX7_EX8del mRNA isoforms. In contrast to a previously identified EX7_EX8del isoform, P2RX7E, it was predicted that P2RX7L would retain the long intracellular C-terminus including key structural motifs required for cell surface localization. 36, 37 In HEK 293 cells, both P2RX7E and P2RX7L, were translated into P2X7E and P2X7L protein isoforms, respectively ( Figure 4A ), but only P2X7L was expressed on the cell surface ( Figure 4B ). Lack of surface expression of P2X7E is consistent with previous studies that show the long C-terminus is required for membrane trafficking and localization. 36, 46 P2X7B, which has the same alternative C-terminus as P2X7E, has previously been shown to inefficiently traffic to the cell surface. 47 In singly transfected cells P2X7L formed homotrimers ( Figure 6A, lane 3) , and in double transfected cells co-assembled with P2X7A to form heterotrimers ( Figure 6B, lane 2) . It is of interest that the P2X7 L4 mAb bound to P2X7A and not to P2X7L ( Figure 6B ), which would be consistent with loss of the L4 epitope around Arg307 resulting from skipping of exons 7 and 8.
There is considerable interindividual variation in P2X7 receptor function, including channel gating, ion sensitivity, and ligand binding. 25, 48 This variation has been largely attributed to inheritance of amino acid-altering non-synonymous SNPs. 2 However, the present study shows that partial allele-specific alternative splicing may potentially affect receptor function by altering the proportional of fully functional P2X7A homotrimers expressed at the cell surface through the formation of heteromers. Double-expression of P2X7A and P2X7L in a cell model reduced receptor pore function by ~50%, and a previous study in 200 healthy human subjects found mutations at rs208307, labeled as "IVS6 G-5C" in Denlinger et al, 24 and rs36144485 (IVS6 TTTG-17TTTGTTTG), were present in those with low pore function who were wild-type at the rs3751143 (A1513C) loss-of-function SNP. 24 The recognition that partial allele-specific alternative splicing produces functional P2X7 protein isoforms that alter receptor function adds complexity to the design and interpretation of P2RX7 genetic association studies. Most studies of P2RX7 and disease have focused on non-synonymous SNPs that alter protein sequence; however, this present study has found intronic SNPs that contribute to variation of protein sequence between individuals and an examination of rs208307 allele frequencies in previous candidate-gene F I G U R E 9 P2X7 receptor pore function is altered following co-assembly of P2X7A with P2X7L. HEK 293 cells were singly transfected with P2X7A (A), P2X7E (E), or P2X7l (L) or doubletransfected with P2X7A and P2X7E (A + E) or P2X7L (A + L). Pore function was measured as the rate of ethidium uptake using a plate reader-based assay (n = 2-7). Co-transfection with equal amounts of P2X7A and P2X7L significantly decreased the rate of ethidium uptake compared to transfection with P2X7A alone. One-way ANOVA with Tukey's post hoc analyses *P < .0001. NT, non-transfected cells | 17 SKARRATT eT Al. and disease association studies may be considered in light of the phenotypic consequences of allele-specific alternative splicing. 42 The consequences of allele-and tissue-specific alternative splicing on P2X7 protein isoform expression have important practical applications for P2X7 as a pharmacological target. The presence of tissue-specific isoforms may aid the design of drugs with specific actions on given P2X7-dependent physiological processes. Furthermore, an understanding of alternative splicing is required for emerging RNA therapies that use RNA interference methods to silence specific mRNA isoforms.
In conclusion, we have identified a component of the genetic regulation of P2RX7E and P2RX7L mRNA levels in native human cells and found that the P2X7L protein isoform alters pore and phagocytic function in a cell model. Although a previous study found a potential association between rs208307 and rs36144485 and low pore function in human subjects, 24 further studies are required to fully characterize the effects of P2X7L on receptor function. At present, studies are limited by the absence of antibodies that differentiate EX7_EX8del protein isoforms from P2X7A, however advances in proteomic techniques are expected to provide a better understanding of P2X7 receptor structure and function resulting from alternative splicing.
